GlassScriptPhysician profile
Andrew Salib
NPI 1811420300
$6,528.64
in general payments reported to CMS, 2019-2025
30 companies · $1,708 in 2025
The $1,708 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $81.92 · 2021: $478 · 2022: $1,206 · 2023: $2,056 · 2024: $624 · 2025: $1,708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,733 · Travel and Lodging: $1,371 · Consulting Fee: $1,150 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,732.89 |
| Travel and Lodging | $1,371.36 |
| Consulting Fee | $1,150.00 |
| Education | $135.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $1,422.20 | 2025 | |
| Coloplast Corp | $1,291.30 | 2021-2024 | Titan |
| Medtronic, INC. | $1,159.44 | 2021-2024 | Interstim |
| Astellas Pharma US INC | $526.25 | 2019-2023 | |
| Boston Scientific Corporation | $311.97 | 2019-2024 | Solyx Sis System |
| Photocure INC | $260.55 | 2022-2023 | Cysview |
| Intuitive Surgical, INC. | $155.28 | 2022-2023 | Da Vinci Surgical System |
| Abbvie INC. | $154.18 | 2022-2024 | |
| Procept Biorobotics Corporation | $142.48 | 2024 | Aquabeam System |
| Medtronic USA, INC. | $135.66 | 2019-2020 | |
| Palette Life Sciences, INC. | $116.63 | 2023 | |
| Axonics, INC. | $111.54 | 2023 | Axonics |
| Sumitomo Pharma America, INC. | $105.95 | 2024-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $98.88 | 2023 | Keytruda |
| Janssen Biotech, INC. | $97.47 | 2021-2025 | Erleada |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $81.00 | 2024 | |
| Immunitybio, INC. | $48.11 | 2025 | |
| Ferring Pharmaceuticals INC. | $38.27 | 2024 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Telix Pharmaceuticals | $31.34 | 2025 | Illuccix |
| Calyxo, INC. | $26.77 | 2025 | Cvac Aspiration System |
| Dendreon Pharmaceuticals LLC | $25.61 | 2024 | Provenge |
| Olympus America INC. | $22.63 | 2025 | Soltive |
| Teleflex LLC | $22.12 | 2022 | |
| 180 Medical, INC. | $20.28 | 2024 | |
| Pfizer INC. | $19.70 | 2025 | |
| Allergan, INC. | $18.60 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.08 | 2025 | |
| Antares Pharma, INC. | $15.99 | 2024 | Xyosted |
| Baxter Healthcare | $15.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Salib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.